Zoetis (ZTS) Tops Q2 EPS by 7c. raises guidance

Zoetis (NYSE: ZTS) reported Q2 EPS of $1.56, $0.07 better than the analyst estimate of $1.49. Revenue for the quarter came in at $2.36 billion versus the consensus estimate of $2.31 billion.

GUIDANCE:

Zoetis sees FY2024 EPS of $5.78-$5.88, versus the consensus of $5.77. Zoetis sees FY2024 revenue of $9.1-9.25 billion, versus the consensus of $9.15 billion.

For earnings history and earnings-related data on Zoetis (ZTS) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• Worthington Industries (WOR) Misses Q4 EPS by 9c